Current debate on the use of antibiotic prophylaxis for caesarean section

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 2, 2011, Pages 193-201

  Lamont, R F ^a,b   Sobel, J D ^b   Kusanovic, J P ^a,b   Vaisbuch, E ^a,b   Mazaki Tovi, S ^a,b   Kim, S K ^a   Uldbjerg, N ^a   Romero, R ^a,b  

^a HUTZEL HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; caesarean section; endometritis; pregnancy; prophylaxis; surgical site infections

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; METRONIDAZOLE;

CESAREAN SECTION; EVIDENCE BASED PRACTICE; HUMAN; INFECTION; MORBIDITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UMBILICAL CORD;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TIME FACTORS;

EID: 78650406010     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02729.x     Document Type: Review

References (164)

1. Burke JF,. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.
2. Berg CJ, Chang J, Callaghan WM, Whitehead SJ,. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 2003; 101: 289-96.
3. Cruse P,. Wound infection surveillance. Rev Infect Dis 1981; 3: 734-7.
4. Cruse PJ, Foord R,. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60: 27-40.
5. Boyce JM, Potter-Bynoe G, Dziobek L,. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990; 11: 89-93.
6. Poulsen KB, Bremmelgaard A, Sorensen AI, Raahave D, Petersen JV,. Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect 1994; 113: 283-95.
7. Vegas AA, Jodra VM, Garcia ML,. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993; 9: 504-10.
8. Albers BA, Patka P, Haarman HJ, Kostense PJ,. [Cost effectiveness of preventive antibiotic administration for lowering risk of infection by 0.25%]. Unfallchirurg 1994; 97: 625-8.
9. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122: 160-6.
10. Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1): S51-61.
11. Martone WJ, Jarvis WR, Culver DH, Haley RW,. Incidence and nature of endemic and epidemic nosocomial infections. In:, Bennett JV, Brachman PS, editors. Hospital Infections. Boston: Little, Brown and Co; 1992. pp. 577-96.
12. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP,. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281-6.
13. Fiore MT, Pearlman MD, Chapman RL, Bhatt-Mehta V, Faix RG,. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001; 98: 1075-9.
14. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999; 56: 1839-88.
15. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR,. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250-78.
16. Smaill F, Hofmeyr GJ,. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev 2002; (3): CD000933.
17. Bratzler DW, Houck PM,. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-15.
18. Centers for Medicare and Medicaid Services. 2008 Physician Quality Reporting Initiative Specifications Document. 2007; 1-341. 1-14-2010.
19. Lamont RF, Haynes SVZ,. Prevention of infection following gynaecological surgery-the evidence. In:, O'Donovan PJ, editor. Complications in Gynaecological Surgery. Prevention and Management. London: Barnes and Noble; 2008. pp. 1-10.
20. ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2006; 108: 225-34.
21. Mittendorf R, Aronson MP, Berry RE, Williams MA, Kupelnick B, Klickstein A, et al. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol 1993; 169: 1119-24.
22. Centers for Disease Control and Prevention NCfHS. Vital and Health Statistics, Detailed Diagnoses and Procedures, National Hosptial Discharge Survey, 1994. 127. DHHS Publication. Atlanta, GA: CDC, 1997.
23. Emori TG, Gaynes RP,. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-42.
24. Kaimal AJ, Zlatnik MG, Cheng YW, Thiet MP, Connatty E, Creedy P, et al. Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of postcesarean delivery surgical-site infections. Am J Obstet Gynecol 2008; 199: 310-5.
25. Fry DE,. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9: 579-84.
26. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS,. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33 (Suppl 2): S69-77.
27. Hebert PR, Reed G, Entman SS, Mitchel EF Jr, Berg C, Griffin MR,. Serious maternal morbidity after childbirth: prolonged hospital stays and readmissions. Obstet Gynecol 1999; 94: 942-7.
28. Henderson E, Love EJ,. Incidence of hospital-acquired infections associated with caesarean section. J Hosp Infect 1995; 29: 245-55.
29. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R,. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003; 9: 196-203.
30. Chaim W, Bashiri A, Bar-David J, Shoham-Vardi I, Mazor M,. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol 2000; 8: 77-82.
31. Gibbs RS,. Clinical risk factors for puerperal infection. Obstet Gynecol 1980; 55 (Suppl 5): 178S-84S.
32. Bagratee JS, Moodley J, Kleinschmidt I, Zawilski W,. A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery. BJOG 2001; 108: 143-8.
33. Barwolff S, Sohr D, Geffers C, Brandt C, Vonberg RP, Halle H, et al. Reduction of surgical site infections after Caesarean delivery using surveillance. J Hosp Infect 2006; 64: 156-61. (Pubitemid 44688596)
34. Couto RC, Pedrosa TM, Nogueira JM, Gomes DL, Neto MF, Rezende NA,. Post-discharge surveillance and infection rates in obstetric patients. Int J Gynaecol Obstet 1998; 61: 227-31.
35. Ehrenkranz NJ, Blackwelder WC, Pfaff SJ, Poppe D, Yerg DE, Kaslow RA,. Infections complicating low-risk cesarean sections in community hospitals: efficacy of antimicrobial prophylaxis. Am J Obstet Gynecol 1990; 162: 337-43.
36. Hager RM, Daltveit AK, Hofoss D, Nilsen ST, Kolaas T, Oian P, et al. Complications of cesarean deliveries: rates and risk factors. Am J Obstet Gynecol 2004; 190: 428-34.
37. Martens MG, Kolrud BL, Faro S, Maccato M, Hammill H,. Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. J Reprod Med 1995; 40: 171-5.
38. Mitt P, Lang K, Peri A, Maimets M,. Surgical-site infections following cesarean section in an Estonian university hospital: postdischarge surveillance and analysis of risk factors. Infect Control Hosp Epidemiol 2005; 26: 449-54.
39. Nielsen TF, Hokegard KH,. Cesarean section and intraoperative surgical complications. Acta Obstet Gynecol Scand 1984; 63: 103-8.
40. Noy D, Creedy D,. Postdischarge surveillance of surgical site infections: a multi-method approach to data collection. Am J Infect Control 2002; 30: 417-24.
41. Reilly J, Allardice G, Bruce J, Hill R, McCoubrey J,. Procedure-specific surgical site infection rates and postdischarge surveillance in Scotland. Infect Control Hosp Epidemiol 2006; 27: 1318-23.
42. Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A,. Risk factors for postcesarean surgical site infection. Obstet Gynecol 2000; 95: 367-71.
43. Vermillion ST, Lamoutte C, Soper DE, Verdeja A,. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol 2000; 95: 923-6.
44. Koroukian SM,. Relative risk of postpartum complications in the Ohio Medicaid population: vaginal versus cesarean delivery. Med Care Res Rev 2004; 61: 203-24.
45. Nielsen TF, Hokegard KH,. Postoperative cesarean section morbidity: a prospective study. Am J Obstet Gynecol 1983; 146: 911-6.
46. Yokoe DS, Christiansen CL, Johnson R, Sands KE, Livingston J, Shtatland ES, et al. Epidemiology of and surveillance for postpartum infections. Emerg Infect Dis 2001; 7: 837-41.
47. Vanhems P, Dumas AM, Berland M, Brochery PC, Croidieu C, Gillet JY, et al. Hospital-acquired infections in French maternity units: trends noted in 2-year surveillance (1997-1998). Study Group of Nosocomial Infections in Maternity Units of South-east France. J Hosp Infect 2000; 45: 334-5.
48. van Ham MA, van Dongen PW, Mulder J,. Maternal consequences of caesarean section. A retrospective study of intra-operative and postoperative maternal complications of caesarean section during a 10-year period. Eur J Obstet Gynecol Reprod Biol 1997; 74: 1-6.
49. Creedy DK, Noy DL,. Postdischarge surveillance after cesarean section. Birth 2001; 28: 264-9.
50. Gibbs RS, Jones PM, Wilder CJ,. Internal fetal monitoring and maternal infection following cesarean section. A prospective study. Obstet Gynecol 1978; 52: 193-7.
51. Gilstrap LC III, Cunningham FG,. The bacterial pathogenesis of infection following cesarean section. Obstet Gynecol 1979; 53: 545-9.
52. Hillan EM,. Postoperative morbidity following Caesarean delivery. J Adv Nurs 1995; 22: 1035-42.
53. Miner AL, Sands KE, Yokoe DS, Freedman J, Thompson K, Livingston JM, et al. Enhanced identification of postoperative infections among outpatients. Emerg Infect Dis 2004; 10: 1931-7.
54. Opoien HK, Valbo A, Grinde-Andersen A, Walberg M,. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand 2007; 86: 1097-102.
55. Ward VP, Charlett A, Fagan J, Crawshaw SC,. Enhanced surgical site infection surveillance following caesarean section: experience of a multicentre collaborative post-discharge system. J Hosp Infect 2008; 70: 166-73.
56. Enkin MW, Enkin E, Chalmers I, Hemminki E,. Prophylactic antibiotics in association with caesarean section. In:, Chalmers I, Enkin MW, Keirse MJNC, editors. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press; 1989. pp. 1246-69.
57. Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth JC, Cassell GH,. Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum. Obstet Gynecol 1995; 85: 509-14.
58. Burrows LJ, Meyn LA, Weber AM,. Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol 2004; 103: 907-12.
59. Noyes N, Berkeley AS, Freedman K, Ledger W,. Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients. Infect Dis Obstet Gynecol 1998; 6: 220-3.
60. Beattie PG, Rings TR, Hunter MF, Lake Y,. Risk factors for wound infection following caesarean section. Aust N Z J Obstet Gynaecol 1994; 34: 398-402.
61. Johnson A, Young D, Reilly J,. Caesarean section surgical site infection surveillance. J Hosp Infect 2006; 64: 30-5.
62. Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ,. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol 2008; 29: 477-84.
63. Rudge MV, Atallah AN, Peracoli JC, Tristao AR, Mendonca NM,. Randomized controlled trial on prevention of postcesarean infection using penicillin and cephalothin in Brazil. Acta Obstet Gynecol Scand 2006; 85: 945-8.
64. Leth RA, Moller JK, Thomsen RW, Uldbjerg N, Norgaard M,. Risk of selected postpartum infections after cesarean section compared with vaginal birth: a five-year cohort study of 32,468 women. Acta Obstet Gynecol Scand 2009; 1-8 [Epub ahead of print].
65. Hamilton BE, Martin JA, Ventura SJ,. Births: preliminary data for 2005. Natl Vital Stat Rep 2006; 55: 1-18.
66. Desjardins C, Diallo HO, Audet-Lapointe P, Harel F,. [Retrospective study of post-cesarean endometritis. 1992-1993, Notre-Dame Hospital, Montreal, Canada]. J Gynecol Obstet Biol Reprod (Paris) 1996; 25: 419-23.
67. Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA,. Risk factors for surgical-site infections following cesarean section. Infect Control Hosp Epidemiol 2001; 22: 613-7.
68. Magann EF, Washburne JF, Harris RL, Bass JD, Duff WP, Morrison JC,. Infectious morbidity, operative blood loss, and length of the operative procedure after cesarean delivery by method of placental removal and site of uterine repair. J Am Coll Surg 1995; 181: 517-20.
69. Webster J,. Post-caesarean wound infection: a review of the risk factors. Aust N Z J Obstet Gynaecol 1988; 28: 201-7.
70. Watts DH, Krohn MA, Hillier SL, Eschenbach DA,. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990; 75: 52-8.
71. Centers for Disease Control and Prevention. Semiannual Report: Aggregated Data from the National Nosocomial Infections Surveillance (NNIS) System. Atlanta, GA: CDC, 2000. pp. 1-37. 1-19-2010.
72. Eggebo TM, Gjessing LK,. [Hemorrhage after Cesarean section]. Tidsskr Nor Laegeforen 2000; 120: 2864-6.
73. Watson WJ, George RJ, Welter S, Day D,. High-risk obstetric patients. Maternal morbidity after cesareans. J Reprod Med 1997; 42: 267-70.
74. Maharaj D,. Puerperal pyrexia: a review. Part I. Obstet Gynecol Surv 2007; 62: 393-9.
75. Myles TD, Gooch J, Santolaya J,. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 2002; 100: 959-64.
76. Schneid-Kofman N, Sheiner E, Levy A, Holcberg G,. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet 2005; 90: 10-5.
77. Ramsey PS, White AM, Guinn DA, Lu GC, Ramin SM, Davies JK, et al. Subcutaneous tissue reapproximation, alone or in combination with drain, in obese women undergoing cesarean delivery. Obstet Gynecol 2005; 105: 967-73.
78. Centers for Disease Control and Prevention. Surgical Site Infections (SSIs): Resources for Patients and Healthcare Providers. Atlanta, GA: CDC, 2010.
79. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System 1. Am J Med 1991; 91: 152S-7S.
80. Althabe F, Belizan JM,. Caesarean section: the paradox. Lancet 2006; 368: 1472-3.
81. Brennan DJ, Robson MS, Murphy M, O'Herlihy C,. Comparative analysis of international cesarean delivery rates using 10-group classification identifies significant variation in spontaneous labor. Am J Obstet Gynecol 2009; 201: 308.
82. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al. Births: final data for 2005. Natl Vital Stat Rep 2007; 56: 1-103.
83. DeFrances CJ, Cullen KA, Kozak LJ,. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2007; 165: 1-209.
84. Tita AT, Rouse DJ, Blackwell S, Saade GR, Spong CY, Andrews WW,. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009; 113: 675-82.
85. Coleman VH, Lawrence H, Schulkin J,. Rising cesarean delivery rates: the impact of cesarean delivery on maternal request. Obstet Gynecol Surv 2009; 64: 115-9.
86. Druzin ML, El-Sayed YY,. Cesarean delivery on maternal request: wise use of finite resources? A view from the trenches Semin Perinatol 2006; 30: 305-8.
87. MacDorman MF, Menacker F, Declercq E,. Cesarean birth in the United States: epidemiology, trends, and outcomes. Clin Perinatol 2008; 35: 293-307, v.
88. Minkoff H, Powderly KR, Chervenak F, McCullough LB,. Ethical dimensions of elective primary cesarean delivery. Obstet Gynecol 2004; 103: 387-92.
89. Bettes BA, Coleman VH, Zinberg S, Spong CY, Portnoy B, DeVoto E, et al. Cesarean delivery on maternal request: obstetrician-gynecologists' knowledge, perception, and practice patterns. Obstet Gynecol 2007; 109: 57-66.
90. NIH State-of-the-Science Conference Statement on cesarean delivery on maternal request. NIH Consens State Sci Statements 2006; 23: 1-29.
91. American College of Obstetricians and Gynecologists. ACOG practice bulletin number 47, October 2003: Prophylactic antibiotics in labor and delivery. Obstet Gynecol 2003; 102: 875-82.
92. Ganesh V, Apuzzio JJ, Dispenziere B, Patel K, Bergen B, Louria DB,. Single-dose trimethoprim-sulfamethoxazole prophylaxis for cesarean section. Am J Obstet Gynecol 1986; 154: 1113-4.
93. Saltzman DH, Eron LJ, Kay HH, Sites JG,. Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section. Obstet Gynecol 1985; 65: 655-7.
94. Chelmow D, Ruehli MS, Huang E,. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gynecol 2001; 184: 656-61.
95. Hawrylyshyn PA, Bernstein P, Papsin FR,. Short-term antibiotic prophylaxis in high-risk patients following cesarean section. Am J Obstet Gynecol 1983; 145: 285-9.
96. Jakobi P, Weissman A, Zimmer EZ, Paldi E,. Single-dose cefazolin prophylaxis for cesarean section. Am J Obstet Gynecol 1988; 158: 1049-52.
97. McGregor JA, French JI, Makowski E,. Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients. Am J Obstet Gynecol 1986; 154: 955-60.
98. Saltzman DH, Eron LJ, Tuomala RE, Protomastro LJ, Sites JG,. Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section. A comparative trial. J Reprod Med 1986; 31: 709-12.
99. Andrews WW, Hauth JC, Cliver SP, Savage K, Goldenberg RL,. Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. Obstet Gynecol 2003; 101: 1183-9.
100. Dinsmoor MJ, Gilbert S, Landon MB, Rouse DJ, Spong CY, Varner MW, et al. Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol 2009; 114: 752-6.
101. Chelmow D, Hennesy M, Evantash EG,. Prophylactic antibiotics for non-laboring patients with intact membranes undergoing cesarean delivery: an economic analysis. Am J Obstet Gynecol 2004; 191: 1661-5.
102. Liabsuetrakul T, Chongsuvivatwong V, Lumbiganon P, Lindmark G,. Obstetricians' attitudes, subjective norms, perceived controls, and intentions on antibiotic prophylaxis in caesarean section. Soc Sci Med 2003; 57: 1665-74.
103. Liabsuetrakul T, Islam M,. Evidence on antibiotic prophylaxis for cesarean section alone is not sufficient to change the practices of doctors in a teaching hospital. J Obstet Gynaecol Res 2005; 31: 202-9.
104. Huskins WC, Ba-Thike K, Festin MR, Limpongsanurak S, Lumbiganon P, Peedicayil A, et al. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet 2001; 73: 141-5.
105. Pedersen TK, Blaakaer J,. Antibiotic prophylaxis in cesarean section. Acta Obstet Gynecol Scand 1996; 75: 537-9.
106. Mallaret MR, Blatier JF, Racinet C, Fauconnier J, Favier M, Micoud M,. [Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection]. J Gynecol Obstet Biol Reprod (Paris) 1990; 19: 1061-4.
107. Mugford M, Kingston J, Chalmers I,. Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources. BMJ 1989; 299: 1003-6.
108. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH,. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993; 128: 79-88.
109. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584-99.
110. Gilstrap LC III,. Prophylactic antibiotics for cesarean section and surgical procedures. J Reprod Med 1988; 33 (Suppl 6): 588-90.
111. Howie PW, Davey PG,. Prophylactic antibiotics and caesarean section. BMJ 1990; 300: 2-3.
112. Suonio S, Saarikoski S, Vohlonen I, Kauhanen O,. Risk factors for fever, endometritis and wound infection after abdominal delivery. Int J Gynaecol Obstet 1989; 29: 135-42.
113. Centers for Disease Control. Births: Preliminary Data for 2006. National vital statistics reports. 56, 18. 1-18-2010. Atlanta, GA: CDC, 2008.
114. Hopkins L, Smaill F,. Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst Rev 2000; (2): CD001136.
115. Agency for Healthcare research and Quality. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence report/technology assessment No.43. AHRQ Publication No.01-E058. 1-15-2010. Atlanta, GA: CDC, 2001.
116. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC,. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996; 175: 974-6.
117. Edwards RK, Clark P, Sistrom CL, Duff P,. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol 2002; 100: 534-9.
118. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG,. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 1999; 180: 1345-8.
119. Cunningham FG, Leveno KJ, DePalma RT, Roark M, Rosenfeld CR,. Perioperative antimicrobials for cesarean delivery: before or after cord clamping? Obstet Gynecol 1983; 62: 151-4.
120. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG,. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121: 689-96.
121. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000; 105: 21-6.
122. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-7.
123. Renz-Polster H, David MR, Buist AS, Vollmer WM, O'Connor EA, Frazier EA, et al. Caesarean section delivery and the risk of allergic disorders in childhood 1. Clin Exp Allergy 2005; 35: 1466-72.
124. Kozyrskyj AL, Ernst P, Becker AB,. Increased risk of childhood asthma from antibiotic use in early life. Chest 2007; 131: 1753-9.
125. Tan S, Holliman R, Russell AR,. Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes. Lancet 2003; 361: 437.
126. Getahun D, Strickland D, Zeiger RS, Fassett MJ, Chen W, Rhoads GG, et al. Effect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med 2010; 164: 187-92.
127. Dietert RR, Zelikoff JT,. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res B Dev Reprod Toxicol 2008; 83: 547-60.
128. Martel MJ, Rey E, Malo JL, Perreault S, Beauchesne MF, Forget A, et al. Determinants of the incidence of childhood asthma: a two-stage case-control study. Am J Epidemiol 2009; 169: 195-205.
129. Jordan S, Storey M, Morgan G,. Antibiotics and allergic disorders in childhood. Open Nurs J 2008; 2: 48-57.
130. Rusconi F, Galassi C, Forastiere F, Bellasio M, De SM, Ciccone G, et al. Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med 2007; 175: 16-21.
131. Benn CS, Thorsen P, Jensen JS, Kjaer BB, Bisgaard H, Andersen M, et al. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol 2002; 110: 72-7.
132. Gordon HR, Phelps D, Blanchard K,. Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstet Gynecol 1979; 53: 151-6.
133. Fejgin MD, Markov S, Goshen S, Segal J, Arbel Y, Lang R,. Antibiotic for cesarean section: the case for 'true' prophylaxis. Int J Gynaecol Obstet 1993; 43: 257-61.
134. Sullivan SA, Smith T, Chang E, Hulsey T, Vandorsten JP, Soper D,. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol 2007; 196: 455.
135. Thigpen BD, Hood WA, Chauhan S, Bufkin L, Bofill J, Magann E, et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol 2005; 192: 1864-8.
136. Wax JR, Hersey K, Philput C, Wright MS, Nichols KV, Eggleston MK, et al. Single dose cefazolin prophylaxis for postcesarean infections: before vs. after cord clamping. J Matern Fetal Med 1997; 6: 61-5.
137. Costantine MM, Rahman M, Ghulmiyah L, Byers BD, Longo M, Wen T, et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008; 199: 301-6.
138. Owens SM, Brozanski BS, Meyn LA, Wiesenfeld HC,. Antimicrobial prophylaxis for cesarean delivery before skin incision. Obstet Gynecol 2009; 114: 573-9.
139. Yildirim G, Gungorduk K, Guven HZ, Aslan H, Celikkol O, Sudolmus S, et al. When should we perform prophylactic antibiotics in elective cesarean cases? Arch Gynecol Obstet 2009; 280: 13-8.
140. Romero R, Mazor M,. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553-84.
141. Evans LC, Combs CA,. Increased maternal morbidity after cesarean delivery before 28 weeks of gestation. Int J Gynaecol Obstet 1993; 40: 227-33.
142. Seo K, McGregor JA, French JI,. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992; 79: 75-80.
143. Watts DH, Krohn MA, Hillier SL, Eschenbach DA,. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992; 79: 351-7.
144. Emmons SL, Krohn M, Jackson M, Eschenbach DA,. Development of wound infections among women undergoing cesarean section. Obstet Gynecol 1988; 72: 559-64.
145. Hoyme UB, Kiviat N, Eschenbach DA,. Microbiology and treatment of late postpartum endometritis. Obstet Gynecol 1986; 68: 226-32.
146. Newton ER, Wallace PA,. Effects of prophylactic antibiotics on endometrial flora in women with postcesarean endometritis. Obstet Gynecol 1998; 92: 262-8.
147. Roberts S, Maccato M, Faro S, Pinell P,. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993; 81: 383-6.
148. Sherman D, Lurie S, Betzer M, Pinhasi Y, Arieli S, Boldur I,. Uterine flora at cesarean and its relationship to postpartum endometritis. Obstet Gynecol 1999; 94: 787-91.
149. Lavery JP, Marcell CC, Walker R,. An association between Ureaplasma urealyticum and endomyometritis after cesarean section. J Ky Med Assoc 1985; 83: 359-62.
150. Watts DH, Hillier SL, Eschenbach DA,. Upper genital tract isolates at delivery as predictors of post-cesarean infections among women receiving antibiotic prophylaxis. Obstet Gynecol 1991; 77: 287-92.
151. Eschenbach DA,. Ureaplasma urealyticum as a cause of postpartum fever. Pediatr Infect Dis 1986; 5 (Suppl 6): S258-61.
152. Keski-Nisula L, Kirkinen P, Katila ML, Ollikainen M, Suonio S, Saarikoski S,. Amniotic fluid U. urealyticum colonization: significance for maternal peripartal infections at term. Am J Perinatol 1997; 14: 151-6.
153. Rosene K, Eschenbach DA, Tompkins LS, Kenny GE, Watkins H,. Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis 1986; 153: 1028-37.
154. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179: 1254-60.
155. Watts DH, Eschenbach DA, Kenny GE,. Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol 1989; 73: 52-60.
156. Archer GL,. Alteration of cutaneous staphylococcal flora as a consequence of antimicrobial prophylaxis. Rev Infect Dis 1991; 13 (Suppl 10): S805-9.
157. Meyer NL, Hosier KV, Scott K, Lipscomb GH,. Cefazolin versus cefazolin plus metronidazole for antibiotic prophylaxis at cesarean section. South Med J 2003; 96: 992-5.
158. O'Leary JA, Mullins JH Jr, Andrinopoulos GC,. Ampicillin vs. ampicillin-gentamicin prophylaxis in high-risk primary cesarean section. J Reprod Med 1986; 31: 27-30.
159. Pitt C, Sanchez-Ramos L, Kaunitz AM,. Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. Obstet Gynecol 2001; 98: 745-50.
160. Tita AT, Owen J, Stamm AM, Grimes A, Hauth JC, Andrews WW,. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. Am J Obstet Gynecol 2008; 199: 303.
161. Tita AT, Hauth JC, Grimes A, Owen J, Stamm AM, Andrews WW,. Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis. Obstet Gynecol 2008; 111: 51-6.
162. Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008; 198: 43-5.
163. Schelonka RL, Waites KB,. Ureaplasma infection and neonatal lung disease. Semin Perinatol 2007; 31: 2-9.
164. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care, 6th edn. Washington DC: American College of Obstetricians and Gynecologists, 2007.